BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10981070)

  • 1. Treatment of diabetic patients with hypertension.
    Birkenhäger WH; Staessen JA
    Curr Hypertens Rep; 1999 Jun; 1(3):225-31. PubMed ID: 10981070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial.
    Birkenhäger WH; Staessen JA; Gasowski J; de Leeuw PW
    J Nephrol; 2000; 13(3):232-7. PubMed ID: 10928302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of antihypertensive treatment in the diabetic patients enrolled in the Systolic Hypertension in Europe (Syst-Eur) trial.
    Gasowski J; Birkenhäger WH; Staessen JA; de Leeuw PW
    Cardiovasc Drugs Ther; 2000 Feb; 14(1):49-53. PubMed ID: 10755200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal?
    Grossman E; Messerli FH; Goldbourt U
    Arch Intern Med; 2000 Sep; 160(16):2447-52. PubMed ID: 10979055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.
    Pahor M; Psaty BM; Alderman MH; Applegate WB; Williamson JD; Furberg CD
    Diabetes Care; 2000 Jul; 23(7):888-92. PubMed ID: 10895836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists and the diabetic patient: a response to recent controversies.
    Poulter NR
    Am J Cardiol; 1998 Nov; 82(9B):40R-41R. PubMed ID: 9822144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of treating hypertension in the elderly: a short commentary on current issues.
    Weber MA
    Am J Geriatr Cardiol; 2003; 12(1):14-8. PubMed ID: 12502910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.
    Califf RM; Granger CB
    Diabetes Care; 1998 Apr; 21(4):655-7. PubMed ID: 9571359
    [No Abstract]   [Full Text] [Related]  

  • 10. Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients.
    Staessen JA; Birkenhäger WH; Fagard RH
    Eur Heart J; 2000 Jan; 21(1):2-7. PubMed ID: 10610733
    [No Abstract]   [Full Text] [Related]  

  • 11. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M
    J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.
    Vijan S; Hayward RA
    Ann Intern Med; 2003 Apr; 138(7):593-602. PubMed ID: 12667032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.
    Berl T; Hunsicker LG; Lewis JB; Pfeffer MA; Porush JG; Rouleau JL; Drury PL; Esmatjes E; Hricik D; Parikh CR; Raz I; Vanhille P; Wiegmann TB; Wolfe BM; Locatelli F; Goldhaber SZ; Lewis EJ;
    Ann Intern Med; 2003 Apr; 138(7):542-9. PubMed ID: 12667024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of antihypertensive drug treatment in elderly patients with isolated systolic hypertension.
    Wang JG; Staessen JA
    Neth J Med; 2001 Jun; 58(6):248-54. PubMed ID: 11395222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antihypertensive therapy in decreasing renal and cardiovascular complications in diabetes mellitus.
    Nosadini R; Abaterusso C; Dalla Vestra M; Bortoloso E; Saller A; Bruseghin M; Sfriso A; Trevisan M
    Nephrol Dial Transplant; 1998; 13 Suppl 8():44-8. PubMed ID: 9870425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial.
    Estacio RO; Schrier RW
    Am J Cardiol; 1998 Nov; 82(9B):9R-14R. PubMed ID: 9822137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trials in isolated systolic hypertension: an update.
    Waeber B
    Curr Hypertens Rep; 2003 Aug; 5(4):329-36. PubMed ID: 12844468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J).
    Kawamori R; Daida H; Tanaka Y; Miyauchi K; Kitagawa A; Hayashi D; Kishimoto J; Ikeda S; Imai Y; Yamazaki T
    BMC Cardiovasc Disord; 2006 Oct; 6():39. PubMed ID: 17029631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.